Moore TJ - Search Results

1

Association of Pharmaceutical Industry Payments to Physicians With Prescription and Medicare Expenditures for Pimavanserin.

Mehta HB, Moore TJ, Alexander GC. Mehta HB, et al. Among authors: moore tj. Psychiatr Serv. 2021 Jan 1;72(1):77-80. doi: 10.1176/appi.ps.202000251. Epub 2020 Aug 25. Psychiatr Serv. 2021. PMID: 32838675

2

Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.

Moore TJ, Zhang H, Anderson G, Alexander GC. Moore TJ, et al. JAMA Intern Med. 2018 Nov 1;178(11):1451-1457. doi: 10.1001/jamainternmed.2018.3931. JAMA Intern Med. 2018. PMID: 30264133 Free PMC article.

3

Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015-2016.

Qiao Y, Alexander GC, Moore TJ. Qiao Y, et al. Among authors: moore tj. Clin Trials. 2019 Jun;16(3):329-333. doi: 10.1177/1740774519839391. Epub 2019 Mar 29. Clin Trials. 2019. PMID: 30922113

4

Estimated costs of pivotal trials for U.S. Food and Drug Administration-approved cancer drugs, 2015-2017.

Hsiue EH, Moore TJ, Alexander GC. Hsiue EH, et al. Among authors: moore tj. Clin Trials. 2020 Apr;17(2):119-125. doi: 10.1177/1740774520907609. Epub 2020 Feb 29. Clin Trials. 2020. PMID: 32114790

5

Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.

Mehta HB, Ehrhardt S, Moore TJ, Segal JB, Alexander GC. Mehta HB, et al. Among authors: moore tj. BMJ Open. 2020 Jun 9;10(6):e039978. doi: 10.1136/bmjopen-2020-039978. BMJ Open. 2020. PMID: 32518212 Free PMC article.

6

Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional study.

Moore TJ, Heyward J, Anderson G, Alexander GC. Moore TJ, et al. BMJ Open. 2020 Jun 11;10(6):e038863. doi: 10.1136/bmjopen-2020-038863. BMJ Open. 2020. PMID: 32532786 Free PMC article.

7

Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018.

Heyward J, Moore TJ, Chen J, Meek K, Lurie P, Alexander GC. Heyward J, et al. Among authors: moore tj. Ann Intern Med. 2020 Dec 15;173(12):956-963. doi: 10.7326/M20-0274. Epub 2020 Sep 29. Ann Intern Med. 2020. PMID: 32986486

8

Assessment of Availability, Clinical Testing, and US Food and Drug Administration Review of Biosimilar Biologic Products.

Moore TJ, Mouslim MC, Blunt JL, Alexander GC, Shermock KM. Moore TJ, et al. JAMA Intern Med. 2021 Jan 1;181(1):52-60. doi: 10.1001/jamainternmed.2020.3997. JAMA Intern Med. 2021. PMID: 33031559 Free PMC article.

9

Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study.

Moore TJ, Wirtz PW, Kruszewski SP, Alexander GC. Moore TJ, et al. BMJ Open. 2021 Aug 13;11(8):e048528. doi: 10.1136/bmjopen-2020-048528. BMJ Open. 2021. PMID: 34389573 Free PMC article.

10

Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease.

Hwang YJ, Alexander GC, An H, Moore TJ, Mehta HB. Hwang YJ, et al. Among authors: moore tj. Neurology. 2021 Sep 28;97(13):e1266-e1275. doi: 10.1212/WNL.0000000000012601. Epub 2021 Aug 13. Neurology. 2021. PMID: 34389652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters